{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:13:34Z","timestamp":1788480814968,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rbmo.2025.105425","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:49:55Z","timestamp":1764391795000},"page":"105425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-5811","authenticated-orcid":false,"given":"Valerie","family":"Uvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Melsens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simke","family":"Demeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Buyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Evers-lebrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"De Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Unuane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Mackens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rbmo.2025.105425_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13075-017-1338-5","article-title":"Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study","volume":"19","author":"Akmatov","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rbmo.2025.105425_bib0002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.22159\/ajpcr.2017.v10i8.18343","article-title":"Antinuclear antibodies in patients with unexplained recurrent abortions","volume":"10","author":"Asaithambi","year":"2017","journal-title":"Asian Journal of Pharmaceutical and Clinical Research"},{"issue":"6","key":"10.1016\/j.rbmo.2025.105425_bib0003","doi-asserted-by":"crossref","first-page":"535","DOI":"10.5144\/0256-4947.1993.535","article-title":"Anticardiolipin and antinuclear antibodies in patients with unexplained recurrent abortions","volume":"13","author":"Bahar","year":"1993","journal-title":"Ann Saudi Med"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105425_bib0004","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2022.12.042","article-title":"Endometriosis is associated with pregnancy loss: a nationwide historical cohort study","volume":"119","author":"Boje","year":"2023","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0897.2005.00349.x","article-title":"Autoantibodies in Argentine women with recurrent pregnancy loss","volume":"55","author":"Bustos","year":"2006","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0006","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13215","article-title":"Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis","volume":"83","author":"Cavalcante","year":"2020","journal-title":"Am J Reprod Immunol."},{"issue":"4","key":"10.1016\/j.rbmo.2025.105425_bib0008","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.semarthrit.2020.03.016","article-title":"Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis","volume":"50","author":"Chen","year":"2020","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.rbmo.2025.105425_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: A prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.rbmo.2025.105425_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/humupd\/2.4.271","article-title":"A fresh look at the causes and treatments of recurrent miscarriage, especially its immunological aspects","volume":"2","author":"Christiansen","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.rbmo.2025.105425_bib0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.autrev.2018.03.002","article-title":"Solid phase assays vs. automated indirect immunofluorescence for detection of antinuclear antibodies","volume":"17","author":"Claessens","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105425_bib0012","doi-asserted-by":"crossref","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"issue":"12","key":"10.1016\/j.rbmo.2025.105425_bib0013","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1038\/s41591-023-02645-5","article-title":"Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss","volume":"29","author":"Essers","year":"2023","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105425_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00541202","article-title":"Prevalence of antinuclear antibodies in patients with habitual abortion and in normal and toxemic pregnancies","volume":"4","author":"Garcia-De La Torre","year":"1984","journal-title":"Rheumatol Int"},{"issue":"3 Pt 1","key":"10.1016\/j.rbmo.2025.105425_bib0015","first-page":"419","article-title":"The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study","volume":"73","author":"Harger","year":"1989","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.rbmo.2025.105425_bib0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/aji.12635","article-title":"Serologic markers of autoimmunity in women with recurrent pregnancy loss","volume":"77","author":"Hefler-Frischmuth","year":"2017","journal-title":"Am J Reprod Immunol."},{"issue":"2","key":"10.1016\/j.rbmo.2025.105425_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12026-023-09430-z","article-title":"Prevalence and sociodemographic correlates of antinuclear antibody testing by indirect immunofluorescence or solid-phase assays in a Spanish population: the Camargo Cohort","volume":"72","author":"Irure-Ventura","year":"2024","journal-title":"Immunol Res"},{"issue":"9","key":"10.1016\/j.rbmo.2025.105425_bib0018","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humrep\/deu299","article-title":"Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0020-7292(94)90246-1","article-title":"Immune dysfunction in patients with unexplained repeated abortions","volume":"45","author":"Konidaris","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105425_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-0378(92)90003-M","article-title":"Autoantibodies in women with primary recurrent spontaneous abortion of unknown etiology","volume":"22","author":"Kwak","year":"1992","journal-title":"J Reprod Immunol"},{"issue":"9","key":"10.1016\/j.rbmo.2025.105425_bib0024","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10815-015-0566-3","article-title":"Association between IL-6 -174 G\/C, IL-6 -634 G\/C, and IFN-\u03b3 +874 A\/T polymorphisms and susceptibility to recurrent pregnancy loss: a meta-analysis","volume":"32","author":"Lee","year":"2015","journal-title":"J Assist Reprod Genet."},{"issue":"6","key":"10.1016\/j.rbmo.2025.105425_bib0025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.tjog.2015.09.001","article-title":"Investigation of the impact of antinuclear antibody on the outcome of in vitro fertilization\/intracytoplasmic sperm injection treatment","volume":"54","author":"Li","year":"2015","journal-title":"Taiwan J Obstet Gynecol."},{"key":"10.1016\/j.rbmo.2025.105425_bib0026","article-title":"Correlation between the presence of antinuclear antibodies and recurrent pregnancy loss: A mini review","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.rbmo.2025.105425_bib0027","first-page":"631","article-title":"Antinuclear antibodies in women with recurrent pregnancy wastage and their prognostic value for immunotherapy","volume":"116","author":"Malinowski","year":"1994","journal-title":"Zentralbl Gynakol"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105425_bib0028","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.fertnstert.2023.02.030","article-title":"Endometriosis and pregnancy loss: the importance of mitigating sources of bias","volume":"120","author":"Manieri Rocha","year":"2023","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105425_bib0029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.30084","article-title":"Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases","volume":"63","author":"Mariz","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0030","first-page":"221","article-title":"Prevalence and clinical significance of antinuclear antibodies in Iranian women with unexplained recurrent miscarriage","volume":"12","author":"Molazadeh","year":"2014","journal-title":"Iran J Reprod Med"},{"issue":"8","key":"10.1016\/j.rbmo.2025.105425_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.820","article-title":"Chromosomal aberrations in pregnancy and fetal loss: Insight on the effect of consanguinity, review of 1625 cases","volume":"7","author":"Najafi","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105425_bib0032","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/s41598-021-86309-9","article-title":"Identifying the causes of recurrent pregnancy loss in consanguineous couples using whole exome sequencing on the products of miscarriage with no chromosomal abnormalities","volume":"11","author":"Najafi","year":"2021","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.rbmo.2025.105425_bib0033","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.1780300601","article-title":"Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women","volume":"30","author":"Petri","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105425_bib0034","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil Steril."},{"issue":"10285","key":"10.1016\/j.rbmo.2025.105425_bib0035","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"issue":"9535","key":"10.1016\/j.rbmo.2025.105425_bib0036","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.rbmo.2025.105425_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/HAB-2011-0236","article-title":"Antiphospholipid and other autoantibodies in a cohort of habitual aborters and healthy multiparous women in Jamaica","volume":"20","author":"Roye-Green","year":"2011","journal-title":"Hum Antibodies"},{"issue":"1","key":"10.1016\/j.rbmo.2025.105425_bib0038","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-0378(94)00906-N","article-title":"Autoantibodies to phospholipids and nuclear antigens in non-pregnant and pregnant Colombian women with recurrent spontaneous abortions","volume":"28","author":"Ruiz","year":"1995","journal-title":"J Reprod Immunol"},{"issue":"2","key":"10.1016\/j.rbmo.2025.105425_bib0039","first-page":"e98","article-title":"Antinuclear antibodies predict a higher number of pregnancy loss in unexplained recurrent pregnancy loss","volume":"166","author":"Sakthiswary","year":"2015","journal-title":"Clin Ter"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105425_bib0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10815-017-0904-8","article-title":"Decreased live births among women of Middle Eastern\/North African ethnicity compared to Caucasian women","volume":"34","author":"Salem","year":"2017","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"10.1016\/j.rbmo.2025.105425_bib0041","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5\u20136","key":"10.1016\/j.rbmo.2025.105425_bib0042","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0897.2006.00434.x","article-title":"Autoantibodies and prediction of reproductive failure","volume":"56","author":"Shoenfeld","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.rbmo.2025.105425_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6895146","article-title":"Exploring systemic autoimmunity in thyroid disease subjects","volume":"2018","author":"Siriwardhane","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0044","doi-asserted-by":"crossref","first-page":"hoy011","DOI":"10.1093\/hropen\/hoy011","article-title":"The rate of euploid miscarriage is increased in the setting of adenomyosis","volume":"2018","author":"Stanekova","year":"2018","journal-title":"Hum Reprod Open"},{"issue":"9","key":"10.1016\/j.rbmo.2025.105425_bib0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.rbmo.2025.105425_bib0046","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0897.2010.00863.x","article-title":"Antinuclear autoantibodies in women with recurrent pregnancy loss","volume":"64","author":"Ticconi","year":"2010","journal-title":"Am J Reprod Immunol."},{"key":"10.1016\/j.rbmo.2025.105425_bib0047","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/humupd\/dmr024","article-title":"Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review","volume":"17","author":"van den Boogaard","year":"2011","journal-title":"Hum Reprod Update"},{"issue":"5 Pt 1","key":"10.1016\/j.rbmo.2025.105425_bib0048","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0002-9378(90)90612-B","article-title":"Antinuclear antibodies in sera of patients with recurrent pregnancy wastage","volume":"163","author":"Xu","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0049","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/aji.12111","article-title":"A further exploration of the impact of antinuclear antibodies on in vitro fertilization-embryo transfer outcome","volume":"70","author":"Ying","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"10.1016\/j.rbmo.2025.105425_bib0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/08820139.2012.660266","article-title":"Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate","volume":"41","author":"Ying","year":"2012","journal-title":"Immunol Invest"},{"issue":"3","key":"10.1016\/j.rbmo.2025.105425_bib0051","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.fertnstert.2017.06.025","article-title":"Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis","volume":"108","author":"Younes","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2025.105425_bib0052","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1477-7827-11-98","article-title":"A retrospective study on IVF\/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment","volume":"11","author":"Zhu","year":"2013","journal-title":"Reprod Biol Endocrinol."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325006327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648325006327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:45:09Z","timestamp":1788479109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648325006327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1472648325006327"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.105425","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2025.105425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105425"}}